SCHEMBL2809936

SCHEMBL2809936

COc1ccc(CN2CCC3NN(Cc4ccccc4)c4nc(N5CCN(CC(=O)N6CCCC6)CC5)nc2c43)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 2/20 0.39
HTT P42858 2/20 0.39
OPRM1 P35372 1/20 0.39
OPRL1 P41146 1/20 0.39
MEN1 O00255 1/20 0.39
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FAAH O00519 1/20 0.38
KDR P35968 1/20 0.37
SIGMAR1 Q99720 2/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811753 0.87 EHMT2 (0.42) KMT2AHTTMEN1SMN1; SMN2SIGMAR1
SCHEMBL2808410 0.86 HTR2A (0.45) ALDH1A1KDM4ETDP1GAALMNA
SCHEMBL2814408 0.85 HRH4 (0.43) SIGMAR1
SCHEMBL2809475 0.85 DNMT3A (0.47) ALDH1A1KDM4ETDP1LMNAKMT2A
SCHEMBL538223 0.82 MAPT (0.41) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL2808265 0.82 TSHR (0.43) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL2814820 0.82 DNMT3A (0.46) ALDH1A1KDM4EDRD4SMN1; SMN2MAPT
SCHEMBL2813884 0.80 HRH3 (0.44) ALDH1A1KDM4EGAAKMT2AHTT
SCHEMBL2813121 0.80 POLB (0.47) ALDH1A1KDM4ELMNAKMT2AHTT
SCHEMBL2809438 0.79 ALDH1A1 (0.47) ALDH1A1KDM4ETDP1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 ALDH1A1 924/4885KDM4E 2749/4885TDP1 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.